Literature DB >> 4988640

Nitroglycerine in angina.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4988640      PMCID: PMC1701181     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  7 in total

1.  Effect of nitroglycerin on the coronary circulation in patients with coronary artery disease or increased left ventricular work.

Authors:  R GORLIN; N BRACHFELD; C MACLEOD; P BOPP
Journal:  Circulation       Date:  1959-05       Impact factor: 29.690

2.  Slit-kymographic evidence that nitroglycerine decreases heart volume and stroke volume while increasing the amplitude of ballistocardiographic waves.

Authors:  J L BRANDT; A CACCESE; W DOCK
Journal:  Am J Med       Date:  1952-06       Impact factor: 4.965

3.  The effect of nitroglycerin on the systemic and coronary circulation in man and dogs: myocardial blood flow measured with xenon.

Authors:  L Bernstein; G C Friesinger; P R Lichtlen; R S Ross
Journal:  Circulation       Date:  1966-01       Impact factor: 29.690

4.  Studies on cardiac dimensions in intact unanesthetized man. V. Effects of nitroglycerin.

Authors:  J F Williams; G Glick; E Braunwald
Journal:  Circulation       Date:  1965-11       Impact factor: 29.690

5.  Effect of nitroglycerin, intensain, isoptin and papaverine on coronary blood flow in man. Measured by the coincidence counting technic and rubidium.

Authors:  E D Luebs; A Cohen; E J Zaleski; R J Bing
Journal:  Am J Cardiol       Date:  1966-04       Impact factor: 2.778

6.  The influence of changes in blood volume on angina pectoris. A study of the effect of phlebotomy.

Authors:  J O Parker; R B Case; F Khaja; J R Ledwich; P W Armstrong
Journal:  Circulation       Date:  1970-04       Impact factor: 29.690

7.  Measurement of the angina threshold using atrial pacing. A new technique for the study of angina pectoris.

Authors:  G E Sowton; R Balcon; D Cross; M H Frick
Journal:  Cardiovasc Res       Date:  1967-10       Impact factor: 10.787

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.